WhitTier Trust Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

WhitTier Trust Company’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,043	Closed	-$272K	–	1065
2017 Q4	$272K	Sell	5,043 -75	-1%	-$4.1K	0.02%	319
2017 Q3	$293K	Hold	5,118	–	–	0.03%	308
2017 Q2	$308K	Buy	5,118 +75	+1%	+$4.27K	0.03%	300
2017 Q1	$275K	Buy	+5,043	New	+$248K	0.03%	307

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

WhitTier Trust Company's BIVV Position: Q1 2018 in Review

WhitTier Trust Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,043 shares — an estimated $272K sold.

WhitTier Trust Company first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $308K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

WhitTier Trust Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
WhitTier Trust Company sold 5,043 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $272K.
WhitTier Trust Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
WhitTier Trust Company's Bioverativ Inc. Common Stock position peaked at $308K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on WhitTier Trust Company's 13F filing for Q1 2018, filed 1 May 2018.